- Home
- APYX vs IMA Comparison
APYX vs IMA Comparison
Compare APYX & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- IMA
- Stock Information
- Founded
- APYX 1982
- IMA 2019
- Country
- APYX United States
- IMA United States
- Employees
- APYX N/A
- IMA N/A
- Industry
- APYX Medical/Dental Instruments
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APYX Health Care
- IMA Health Care
- Exchange
- APYX Nasdaq
- IMA Nasdaq
- Market Cap
- APYX 85.0M
- IMA 92.2M
- IPO Year
- APYX 1987
- IMA N/A
- Fundamental
- Price
- APYX $2.39
- IMA $8.60
- Analyst Decision
- APYX Hold
- IMA
- Analyst Count
- APYX 1
- IMA 0
- Target Price
- APYX N/A
- IMA N/A
- AVG Volume (30 Days)
- APYX 67.6K
- IMA 75.0K
- Earning Date
- APYX 11-07-2025
- IMA 11-15-2025
- Dividend Yield
- APYX N/A
- IMA N/A
- EPS Growth
- APYX N/A
- IMA N/A
- EPS
- APYX N/A
- IMA N/A
- Revenue
- APYX $46,512,000.00
- IMA $4,300,000.00
- Revenue This Year
- APYX $6.03
- IMA N/A
- Revenue Next Year
- APYX $4.96
- IMA N/A
- P/E Ratio
- APYX N/A
- IMA N/A
- Revenue Growth
- APYX N/A
- IMA N/A
- 52 Week Low
- APYX $0.76
- IMA $7.57
- 52 Week High
- APYX $2.73
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- APYX 62.75
- IMA N/A
- Support Level
- APYX $2.06
- IMA N/A
- Resistance Level
- APYX $2.20
- IMA N/A
- Average True Range (ATR)
- APYX 0.16
- IMA 0.00
- MACD
- APYX 0.02
- IMA 0.00
- Stochastic Oscillator
- APYX 98.57
- IMA 0.00
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.